The Extraordinary Dr. Koffman, Who Beat Leukemia.

Dr. Brian Koffman is extraordinary, in many ways. He’s extraordinary in the medical sense because, after twelve years of battling blood cancer, doctors can...

Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million Award from Project...

Vaxart Closes $10 Million Secondary on January 16th @0.65. Vaxart Receives $9 Million Award from Barda on January 19th. Shares trades From a Low of $0.55...

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants We were having cocktails at a fancy restaurant last night with a hedge fund manager, who manages...

GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.

ILLUSTRATION 3 |MISSION AND STRATEGY Our mission: One is to innovate. The other one is to differentiate. The other one is to accelerate and finally...

Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.

Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List Within 30...

Corbus Pharma (CRBP) Explodes Higher After Reverse Split, up 1,288%!

From a Low of $2.11 Just Shy of a Year Ago, to an Intraday High of $29.30. A Ten Bagger in Less Than a...

Zivo Bioscience (ZIVO) Screams 2,608% Higher AFTER Reverse Split!

Okay, that's it. We are officially enamored with post reverse split trading! First, there was our client, LQR House (LQR), then Polished (POL) and...

Top 10 AI Titans.

Delve into the pinnacle of AI innovation. This report is your guide to the seismic shifts in AI startups, the rise of ethical AI,...

Research Report: Society Pass (SOPA) $0.22. Price Target $4.00.

Three New Reports on Society Pass (SOPA) With Price Targets from $3.00 to $4.00. (All Report Archive) December 27th, 2023. Litchfield Hills Research – $4.00 Price...

ATCC Announces $87 Million Award for Project NextGen for Vaccines, from Barda.

ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development...

Latest article

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets.UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!II.Replimune (REPL) $11.23. Gains 28% in Sympathy with UniQure. We...

Adding Bavarian Nordic (BVRNY) $8.91, to Watch List.

Bavarian Nordic Lands $106 Million Contract for its Smallpox/Mpox Vaccine! Were Back for the Third Time! LIVE QUOTE PREVIOUS WRITEUPS Aug 27, 2025: Our 4th Billion Dollar Takeover!...

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...